Gentherm (THRM) Q4 2025 earnings review
Revenue Acceleration Meets Profit Compression
Gentherm closed FY25 with its strongest revenue growth of the year (+8.5% YoY), significantly outperforming light vehicle production. However, this top-line momentum did not flow to the bottom line. Q4 Adjusted EBITDA margin compressed to 10.6% (lowest of the year), and Net Income plummeted 80% to $3.0M due to higher material costs, unfavorable mix, and footprint realignment expenses. While the company secured $2.2B in annual awards and issued constructive FY26 guidance ($1.55B midpoint), the immediate story is one of 'profitless growth' as operational costs weigh heavily on margins.
🐂 Bull Case
Automotive Climate and Comfort Solutions revenue grew 11.1% YoY, outperforming S&P Global light vehicle production by 820 basis points. The company is proving its ability to grow content per vehicle despite a flat macro environment.
Gentherm secured $2.2B in new business awards for the second consecutive year, validating its technology roadmap. Q4 alone added $485M in awards.
🐻 Bear Case
Gross margin fell 70bps YoY to 23.7%, and Adjusted EBITDA margin dropped 110bps to 10.6%. Management cites material costs and 'footprint realignment,' but the inability to convert higher volume into profit is a concern.
GAAP Net Income fell from $15.3M in 24Q4 to just $3.0M in 25Q4. Even on an adjusted basis, EPS excludes significant 'restructuring' costs that are impacting cash flow.
⚖️ Verdict: ⚪
Neutral. The top-line acceleration and market share gains are impressive, but the sharp decline in profitability and earnings quality in Q4 dampens enthusiasm. The FY26 outlook suggests stabilization, but execution on margin recovery is now the critical
Key Themes
Profitability Under Pressure
Despite an 8.5% revenue jump, Adjusted EBITDA margin fell to 10.6%, the lowest point of FY25. The company blames 'higher material costs, including mix' and footprint realignment expenses. This indicates negative operating leverage where costs are rising faster than sales, specifically in the Automotive segment where 'Other Automotive' revenues (cables/electronics) are shrinking while costs remain sticky.
Lumbar & Massage Segment Boom
This sub-segment is the company's clear growth engine, surging 26.5% YoY in Q4 to $58.5M. It significantly outpaced the core Climate Control Seats (+5.9%) and helps offset declines in legacy 'Other Automotive' products (-8.8%). As OEMs look to differentiate interiors, Gentherm's massage solutions are seeing rapid adoption.
Medical Segment Stagnation
The Medical segment continues to be a drag, declining 1.3% YoY in Q4 and remaining flat (-0.1%) for the full year. Despite being a potential diversification lever, it has failed to contribute to growth, raising questions about capital allocation and strategic fit if it cannot scale.
Diversification into Furniture
Gentherm secured a win with a 'second leading global furniture brand' for climate/comfort solutions, with production starting mid-2026. This is a tangible step in their 'adjacent markets' strategy, leveraging automotive tech in home/office settings to reduce reliance on auto cycles.
Footprint Realignment Costs
The company is undergoing a 'footprint realignment' to optimize manufacturing. While intended to save money long-term, it is currently a margin headwind ($12.5M in restructuring expenses for FY25). The benefits of these actions are not yet visible in the P&L, creating execution risk for 2026.
Debt and Leverage
While net leverage is low at 0.2x, the company has $189M in long-term debt. With the pending combination with Modine Performance Technologies, the capital structure complexity may increase. Current cash generation is healthy ($117M OCF FY25), but free cash flow conversion remains a watch item given the CapEx requirements for new plants.
Other KPIs
Up significantly from $0.29 in the prior year (as reported in text), though GAAP EPS fell to $0.10. The wide gap between GAAP and Adjusted numbers ($0.39 difference) highlights the magnitude of 'one-time' restructuring and M&A costs being added back.
Increased 7% YoY from $109.6M in FY24. Cash generation remains resilient despite net income volatility, supporting the company's ability to fund internal investments and the Modine transaction.
Stable compared to $2.4B in FY24. While slightly down YoY, maintaining >$2B in awards supports the narrative of mid-term revenue growth outpacing the market.
Guidance
Accelerating. The midpoint ($1.55B) implies ~3.4% YoY growth, improving upon the 2.9% growth seen in FY25. This assumes low-single-digit decline in vehicle production, implying strong continued market outgrowth.
Stable/Accelerating. Midpoint ($185M) implies ~6% growth vs FY25's $174.8M. Margin implied at midpoint is ~11.9%, a slight expansion from 11.7% in FY25, suggesting management expects some payoff from footprint actions.
Accelerating. Implies ~10% growth in 2027 vs 2026 midpoint. This aggressive target underscores confidence in the order backlog converting to sales and the ramping of new programs.
Stable. The midpoint ($90M) is roughly in line with implied FY25 adjusted levels (OCF $117M - CapEx ~$56M = ~$61M unadjusted FCF). Guidance suggests improved conversion.
Key Questions
Margin Recovery Confidence
With Q4 EBITDA margin compressing to 10.6% despite peak revenue, what specific factors give confidence in hitting the 11.9% implied midpoint for FY26? When do footprint savings actually hit the P&L?
Medical Segment Strategy
Medical revenue has been flat to down for consecutive quarters. Is this segment strategic to the long-term vision, or a candidate for divestiture given the focus on automotive and new adjacent markets like furniture?
Modine Transaction Impact
Guidance explicitly excludes the Modine Performance Technologies combination. Can you quantify the expected integration costs and revenue synergies for FY26 once closed?